Susquehanna Fundamental Investments, LLC Ptc Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	SELL	$38.16 - $48.86 $1.12 Million - $1.43 Million	-29,351 Reduced 24.29%	91,468 $4.43 Million
Q4 2022 Feb 14, 2023	SELL	$33.53 - $54.79 $190,081 - $310,604	-5,669 Reduced 4.48%	120,819 $4.61 Million
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $3.83 Million - $4.93 Million	91,468 Added 261.19%	126,488 $6.35 Million
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $1.17 Million - $1.56 Million	35,020 New	35,020 $1.31 Million

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.